Arnaud Méjean

14.2k citations

226 papers · 7.1k indexed · 2 hit papers · h-index 43

Impact in

Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments
Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment

Papers in

Pulmonary and Respiratory Medicine 160
- Renal cell carcinoma treatment 112
- Renal and Vascular Pathologies 21
- Prostate Cancer Treatment and Research 17
- Prostate Cancer Diagnosis and Treatment 15
Transplantation 12

Co-authors: Stéphane Oudard Jean-Michel Corréas Nicolas Thiounn O. Hélénon Virginie Verkarre Christophe Legendre Alexandre de la Taille Bertrand Dufour
Journals: The Journal of Urology (15 papers)European Urology (11 papers)World Journal of Urology (9 papers)British Journal of Urology (8 papers)Journal of Clinical Oncology (6 papers)
Partner nations: France United States Italy

In The Last Decade

Arnaud Méjean

215 papers receiving 6.9k citations

Hit Papers

align trajectories log scale

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer 2015 · 356 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Clinical Cancer Research
2013 New England Journal of Medicine

Peers

Countries citing papers authored by Arnaud Méjean

Since Specialization

Citations

This map shows the geographic impact of Arnaud Méjean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Méjean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Méjean more than expected).

Fields of papers citing papers by Arnaud Méjean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Méjean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Méjean. The network helps show where Arnaud Méjean may publish in the future.

Co-authors

The 25 scholars most cited alongside Arnaud Méjean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arnaud Méjean Line = papers co-authored together Arnaud Méjean links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Étude CamiCon : évaluation d’un nouvel outil pour la réalisation d’un calendrier mictionnel automatisé et connecté PubMed ·Florence Alameda, François Audenet, E. Mandron, Marc‐Olivier Timsit, E. Fontaine, M. Pietak, Arnaud Méjean, S. Hurel	2024	1
2	Is “Kidney Stone Calculator” efficient in predicting ureteroscopic lithotripsy duration? A holmium:YAG and thulium fiber lasers comparative analysis World Journal of Urology ·M. Chicaud, S. Kutchukian, Steeve Doizi, François Audenet, Laurent Berthe, Laurent Yonneau, Thierry Lebrét, Marc‐Olivier Timsit, Arnaud Méjean, Luigi Candela, Catalina Solano, Mariela Corrales, Igor Duquesne, A. Descazeaud, Olivier Traxer, Frédéric Panthier	2024	4
3	Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension British Journal of Urology ·Pierre Bigot, Jean‐Christophe Bernhard, Z. Khene, Charles Dariane, Souhil Lebdai, N. Doumerc, François Xavier Nouhaud, Idir Ouzaïd, Patrick Saulnier, Arnaud Méjean, Morgan Rouprêt, Karim Bensalah	2023	3
4	Clinical outcomes of adapted hypofractionated radiotherapy for bladder cancer in elderly patients British Journal of Urology ·Fabien Mignot, Emmanuelle Fabiano, Évanguelos Xylinas, A. Alati, Arnaud Méjean, A. Masson-Lecomte, Jean‐François Hermieu, François Desgrandchamps, Christophe Hennequin, C. Durdux, L. Quéro	2023	1
5	A prospective descriptive 1‐year study in France of all BCG therapy dispensations for non‐muscle‐invasive bladder cancer British Journal of Urology ·Y. Neuzillet, Priscilla Léon, Thomas Seisen, Yves Allory, François Audenet, Yohann Loriot, A. Masson-Lecomte, Arnaud Méjean, Benjamin Pradère, M. Roumiguié, Olivier Traxer, Évanguelos Xylinas, Georges Fournier, Morgan Rouprêt	2022	1
6	High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality Cancers ·Charles Dariane, Sylvie Clairefond, Benjamin Péant, Laudine Communal, Zhe Thian, Véronique Ouellet, Dominique Trudel, Nazim Benzerdjeb, Féryel Azzi, Arnaud Méjean, Marc‐Olivier Timsit, Manon Baurès, Jacques‐Emmanuel Guidotti, Vincent Goffin, Pierre I. Karakiewicz, Anne‐Marie Mes‐Masson, Fred Saad	2022	7
7	Using Contrast-Enhanced Ultrasound in Addition to Cross-Sectional Imaging for Indeterminate Renal Cysts May Lead to Overclassification in Bosniak III Category: A Case-Control Study European Surgical Research ·François Audenet, J. Sapetti, Christophe Delavaud, Virginie Verkarre, Jean-Michel Corréas, Arnaud Méjean, Marc‐Olivier Timsit	2021	3
8	Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1 Modern Pathology ·Aurélien Morini, Tom Drossart, Marc‐Olivier Timsit, Mathilde Sibony, Viorel Vasiliu, Anne‐Paule Gimenez‐Roqueplo, Judith Favier, Cécile Badoual, Arnaud Méjean, Nelly Burnichon, Virginie Verkarre	2021	37
9	Apalutamide, Darolutamide and Enzalutamide in Nonmetastatic Castration-Resistant Prostate Cancer: A Meta-Analysis Future Oncology ·M. Roumiguié, Xavier Paolettí, Y. Neuzillet, Romain Mathiéu, S. Vincendeau, F. Kleinclauss, Arnaud Méjean, Laurent Guy, Marc‐Olivier Timsit, Thierry Lebrét	2021	11
10	MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features Modern Pathology ·Thomas Denize, Pierre Alexandre Just, Mathilde Sibony, Hélène Blons, Marc‐Olivier Timsit, Tom Drossart, Déborah Jakubowicz, Chloé Broudin, Aurélien Morini, Thierry Jo Molina, Yann Vano, Marie Auvray-Kuentz, Richard J. Kahnoski, Arnaud Méjean, Anne‐Paule Gimenez‐Roqueplo, Nelly Burnichon, Virginie Verkarre	2020	18
11	A preoperative nomogram to predict major complications after robot assisted partial nephrectomy (UroCCR-57 study) Urologic Oncology Seminars and Original Investigations ·Z. Khene, B. Peyronnet, Jean‐Christophe Bernhard, Neil J. Kocher, Christophe Vaessen, N. Doumerc, Benjamin Pradère, Thomas Seisen, Jean‐Baptiste Beauval, G. Verhoest, M. Roumiguié, Alexandre de la Taille, F. Bruyère, Morgan Rouprêt, Arnaud Méjean, Romain Mathiéu, Shahrokh F. Shariat, Jay D. Raman, Karim Bensalah	2019	7
12	Polymorphisms in the Von Hippel–Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors Clinical Genitourinary Cancer ·Annelies Verbiest, Diether Lambrechts, Thomas Van Brussel, Gabrielle Couchy, Agnieszka Woźniak, Arnaud Méjean, Evelyne Lerut, Stéphane Oudard, Virginie Verkarre, Sylvie Job, Aurélien de Reyniès, Jean‐Pascal Machiels, Jean‐Jacques Patard, Jessica Zucman‐Rossi, Benoit Beuselinck	2018	8
13	Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib Clinical Genitourinary Cancer ·Maxime Vanmechelen, Diether Lambrechts, Thomas Van Brussel, Annelies Verbiest, Gabrielle Couchy, Patrick Schöffski, Herlinde Dumez, Philip R. Debruyne, Evelyne Lerut, Jean‐Pascal Machiels, Vincent R. Richard, Maarten Albersen, Vincent Verschaeve, Stéphane Oudard, Arnaud Méjean, Pascal Wolter, Jessica Zucman‐Rossi, Benoit Beuselinck	2018	4
14	Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation Cancer Research ·Sophie Bernichtein, Natascha Pigat, Nicolas Barry Delongchamps, Florence Boutillon, Virginie Verkarre, Philippe Camparo, Edouard Reyes‐Gomez, Arnaud Méjean, Stéphane Oudard, Eve M. Lepicard, Mélanie Viltard, Jean-Claude Souberbielle, Gérard Friedlander, Thierry Capiod, Vincent Goffin	2016	42
15	Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma Cancer Research ·Clémence Granier, Charles Dariane, Pierre Combe, Virginie Verkarre, Saı̈k Urien, Cécile Badoual, Hélène Roussel, Marion Mandavit, Patrice Ravel, Mathilde Sibony, Lucie Biard, C. Radulescu, Emeline Vinatier, Nadine Benhamouda, Michaël Peyromaure, Stéphane Oudard, Arnaud Méjean, Marc‐Olivier Timsit, Alain Gey, Éric Tartour	2016	163
16	Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer Clinical Cancer Research ·Nicolás A. Giraldo, Étienne Becht, Franck Pagès, Georgios Skliris, Virginie Verkarre, Yann Vano, Arnaud Méjean, Nicolas Saint-Aubert, Laetitia Lacroix, Ivo Natario, Audrey Lupo, Marco Alifano, Diane Damotte, Aurélie Cazes, Frédéric Triebel, Gordon J. Freeman, Marie‐Caroline Dieu‐Nosjean, Stéphane Oudard, Wolf H. Fridman, Catherine Sautès‐Fridman Hit paper breakdown →	2015	356
17	Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting Clinical Cancer Research ·Benoit Beuselinck, Sylvie Job, Étienne Becht, Alexandra Karadimou, Virginie Verkarre, Gabrielle Couchy, Nicolás A. Giraldo, Nathalie Rioux‐Leclercq, Vincent Molinié, Mathilde Sibony, Réza Elaidi, Corinne Teghom, Jean‐Jacques Patard, Arnaud Méjean, Wolf H. Fridman, Catherine Sautès‐Fridman, Aurélien de Reyniès, Stéphane Oudard, Jessica Zucman‐Rossi	2015	230
18	Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel–Lindau Gene Mutation Status European Urology ·Yosra Messai, Sophie Gad, Muhammad Zaeem Noman, Gwénaël Le Teuff, Sophie Couvé, Bassam Janji, Solenne Florence Kammerer, Nathalie Rioux-Leclerc, Meriem Hasmim, Sophie Ferlicot, Véronique Baud, Arnaud Méjean, David R. Mole, Richard J. Kahnoski, Alexander Eggermont, Laurence Albigès, Fathia Mami‐Chouaib, Bernard Escudier, Salem Chouaı̈b	2015	125
19	Les sites métastatiques atypiques des cancers de la prostate Progrès en Urologie ·Thierry Lebrét, Arnaud Méjean	2008	7
20	Jusqu'où pousser la néphrectomie partielle pour cancer du rein? Annales d Urologie ·Arnaud Méjean	2006	1

About Arnaud Méjean

Arnaud Méjean is a scholar working on Pulmonary and Respiratory Medicine, Transplantation, Urology, Cancer Research and Surgery, having authored 226 papers that have together received 7.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (112 papers), Renal and related cancers (71 papers), Bladder and Urothelial Cancer Treatments (56 papers), Renal and Vascular Pathologies (21 papers), Urinary and Genital Oncology Studies (19 papers), Cancer Genomics and Diagnostics (18 papers), Prostate Cancer Treatment and Research (17 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). The work is most often cited by research in Transplantation (1.1k citations), Pulmonary and Respiratory Medicine (3.9k citations), Cancer Research (1.2k citations), Nephrology (528 citations) and Oncology (1.4k citations). Arnaud Méjean has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Stéphane Oudard, Jean-Michel Corréas, Nicolas Thiounn, O. Hélénon, Virginie Verkarre, Christophe Legendre, Alexandre de la Taille, Bertrand Dufour, Yves Chrétien and Luca Cindolo. Their work appears in journals such as The Journal of Urology, European Urology, World Journal of Urology, British Journal of Urology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact